FNDC5 and sarcopenia: As previously noted, the rise in irisin in chronic liver disease likely represents a mechanistic damage response process, consistent with its overexpression in hepatic stellate cells in significant fibrosis; however, in advanced disease with sarcopenia, irisin levels no longer correlate with muscle mass or disease severity [101,102].